DRD2 and depressive symptom measurement: The unique and selective DRD2-selective partial agonist (−)-IHCH7041 may provide the medical community with chemical tools for exploring signaling pathways that counteract the efficacy and side effects of psychiatric disorders such as depression (Chen et al., 2022).